Buy or sell Ultima Genomics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Ultima Genomics Stock

Ultima Genomics is a developer of a low-cost sequencing platform.

About Ultima Genomics Stock

Ultima Genomics is unleashing the power of genomics at scale. Ultima Genomics drives the scale of genomic information to enable unprecedented advances in biology and improvements in human health. The company was founded in 2016 and is based in Newark, California.

Funding History

May 2022$600M



Doron Lipson

Founder & CEO

Gilad Almogy


Josh Lauer

CTO & Co-Founder

Mark Pratt


David Peoples

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: